Heparin Sodium Salt; 9041-08-1; Heparin Sodium

Name: Heparin Sodium Salt; 9041-08-1; Heparin Sodium
Brand: Nanjing Yanqiao Technology Co., Ltd.
SKU: 2042202562

Jiangsu, ChinaNanjing Yanqiao Technology Co., Ltd.

US$8.50

1-4 g

US$7.00

5-24 g

US$5.50

25-99 g

US$4.50

100+ g

Sample price:US$110.00/piece.Request sample

Product profile

CAS No.

9041-08-1

Formula

(C12h16ns2na3)20

EINECS

232-681-7

Model NO.

YQPR0004

Classification

Biochemical Reagents

Grade

Specific Usage

For Biological Purpose, Technical Grade, Pratical Use

Content

150iu/Mg

Usage

Laboratory Reagents, Teaching Reagents

Source

Habit Appellation

Heparin Sodium Salt

Application

Industry, Agriculture

Property

Biochemical Reagent

Appearance

White Powder

Store

2-8

Potency

150iu/Mg

Purpose

Experimental Study

Transport Package

Plastic Bottle

Specification

1g; 5g; 25g; 100g

Trademark

Origin

China

Production Capacity

90000pieces/Year

Key features

Versatile Applications: Suitable for clinical biochemical, emergency, and hemorheological blood sample collection.

Stable Properties: White amorphous powder, odorless, easily soluble in water, and stable at room temperature.

Multiple Packaging Options: Available in 1g, 5g, 25g, and 100g sizes to meet various laboratory needs.

Low Ion Interference: Recommended for ion content determination as it minimally interferes with other ions.

Non-Irreversible Anticoagulation: Enables test completion within 6 hours to ensure accurate plasma indicators.

Compatible with Separation Gel: Works effectively with separation gel for high-quality plasma sample preparation.

Sterilization Suggestion: Recommended for gamma ray irradiation sterilization at 8-25kGy dose.

Company profile

Nanjing Yanqiao Technology Co., Ltd.Jiangsu, China

Business Type: Trading CompanyExport Year: 2023-01-06Nearest Port: shanghaiAverage Response Time: ≤3.20hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, Others, FCA

AI-Powered supplier vetting

SummaryThe supplier operates across chemical products, new materials, environmental materials, medical devices, laboratory-related products, and technical services. It reports one quality-control inspector, but no quality-control testing equipment, no raw-material traceability identification, random finished-product inspection, and packing-staff checks. Quality assurance is stated, while no written corrective-action or complaint-handling procedures or records were found. The supplier offers flexible customization, minor customization, and customization from samples, but reports no new products in the past year and no ODM, SDK, or well-known-brand OEM capability. One technology engineer supports customer-request confirmation and after-sales technical support. The available information does not establish certifications, production scale, or financial strength. Customer-use references are described by industry and application, but specific customer names or documented cases are not provided.

After-Sales capabilityOne technology engineer is responsible for confirming customer requests and providing technical support for after-sales service. However, the supplier has no written corrective and preventive action procedures or records and no written complaint-handling procedures or records, indicating documented service-process weaknesses despite some technical support capacity.

R&D capabilityThe supplier has one R&D engineer whose stated duties cover customer-request confirmation and after-sales technical support. Nevertheless, it reports no new products in the past year, no ODM service, no SDK, and no well-known-brand OEM capability, providing explicit evidence of limited demonstrated innovation and development services.

Production capacityThe quality infrastructure appears limited: one quality-control or assurance inspector is reported, quality-control test equipment is listed as zero, finished products receive random inspection and are checked by packing staff, and raw materials lack traceability identification. These stated controls indicate a real deficiency in demonstrated production-quality capability.

Customization capabilityThe supplier explicitly offers flexible customization, minor customization, and customization from samples. This directly supports the supplier's ability to accommodate at least these stated customization types.